Close Menu

NEW YORK (GenomeWeb) – The UK's Human Fertilisation and Embryology Authority (HFEA) has granted a license to scientists at the Francis Crick Institute to use CRISPR/Cas9 genome editing in human embryos as part of research on embryo development.

Led by group leader Kathy Niakan, the research will seek to identify genes important to the first seven days of embryo development, as the embryo grows from a single cell into a cluster of more than 200 cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.